KemPharm to Present at the Canaccord Genuity 42nd Annual Growth Conference Aug 2, 2022 07:30AM
KemPharm (KMPH) Acquires Arimoclomol from Orphazyme May 16, 2022 05:20AM
KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline May 15, 2022 08:00PM
KemPharm to Present at Canaccord Genuity 38th Annual Growth Conference Aug 1, 2018 07:30AM
Kempharm (KMPH) PT Raised to $11 at Canaccord Genuity Feb 26, 2018 02:13AM


Aug 10, 2017 07:31AM KemPharm (KMPH) Announces Prelim. Results from KP415 Pharmacokinetic Single and Multiple Dose Trial
Aug 10, 2017 07:30AM KemPharm Announces Preliminary Results from KP415 Pharmacokinetic Single and Multiple Dose Trial
Aug 3, 2017 07:30AM KemPharm to Present at Canaccord Genuity 37th Annual Growth Conference
Dec 20, 2016 08:52AM Canaccord Genuity Assumes Kempharm (KMPH) at Buy
Oct 11, 2016 09:19AM Pre-Open Stock Movers 10/11: (KMPH) (SUPN) (TWLO) Higher; (RCII) (ILMN) (LITE) Lower (more...)
Jul 28, 2016 08:02AM KemPharm to Present at Canaccord Genuity 36th Annual Growth Conference
Feb 9, 2016 04:01PM KemPharm Announces Closing of $86.25 Million 5.50% Senior Convertible Notes Due 2021
Feb 4, 2016 07:30AM KemPharm Announces Pricing of $75.0 Million 5.50% Senior Convertible Notes Due 2021
Aug 4, 2015 07:03AM KemPharm, Inc. to Present at Canaccord Genuity 35th Annual Growth Conference
Aug 4, 2015 07:03AM KemPharm, Inc. to Present at Canaccord Genuity 35th Annual Growth Conference
Jul 2, 2015 09:29AM Canaccord Genuity Raised Price Target on KemPharm (KMPH) Ahead of KP201 Data
May 11, 2015 09:08AM UPDATE: Canaccord Genuity Starts Kempharm (KMPH) at Buy
Apr 16, 2015 10:51AM KemPharm (KMPH) IPO Opens Up 7%
Apr 15, 2015 09:11PM KemPharm Announces Pricing of Initial Public Offering